Novavax (NASDAQ:NVAX), the Gaithersburg, Maryland-based biotech company, still has not submitted its Covid-19 vaccine for emergency use approval (EUA) to the Food and Drug Administration (FDA).
https://finance.yahoo.com/news/novavax-still-not-received-fda-203557252.html